Perimenopause Periods: How Cycles Change, What's Normal, and What Needs Evaluation

The short answer

Erratic timing is expected. Erratic volume is where the important distinctions live. Cycles that arrive every 24 days one month and every 38 days the next are consistent with normal ovarian aging. Bleeding that soaks through a pad or tampon every hour for several hours in a row, passes clots the size of a quarter or larger, lasts more than 7 days, or appears between periods or after sex is not something to file under "just perimenopause" — the American College of Obstetricians and Gynecologists treats those as reasons for evaluation regardless of age. So is any bleeding at all once 12 consecutive months without a period have passed.

This page walks through what happens hormonally to produce these changes, how STRAW+10 stages them, where the line sits between normal variability and abnormal uterine bleeding, which structural causes become far more common in the 40s, how evaluation actually works, and why contraception still matters while cycles are unpredictable.

Why cycles become erratic: what is actually happening in the ovary

The pool of ovarian follicles declines steadily from before birth, and in the 40s the decline reaches a point where the remaining follicles respond less predictably to pituitary signals. The first measurable consequence is usually a shorter cycle, not a longer one. The follicular phase — the first half of the cycle, before ovulation — contracts because rising follicle-stimulating hormone (FSH) recruits a dominant follicle faster. A woman who ran a reliable 29-day cycle in her late 30s may notice 25- and 26-day cycles in her mid-40s and assume nothing has changed, because nothing has become irregular yet.

The next phase is far less orderly. Some cycles ovulate normally and produce a normal luteal phase with progesterone. Others recruit a follicle that never ovulates, so no corpus luteum forms and no progesterone is produced. In those anovulatory cycles the endometrium is exposed to estrogen with nothing opposing it. It keeps proliferating until it outgrows its blood supply and sheds in an unstructured way — which is why the heaviest, most prolonged bleeds of a woman's life often occur in her late 40s rather than her teens.

This also explains the counterintuitive fact that estrogen in perimenopause is not simply 'low.' Individual cycles can produce estradiol levels higher than in the reproductive years, alternating with cycles that produce very little. The symptom pattern — hot flashes one month, breast tenderness and heavy bleeding the next — reflects that oscillation rather than a smooth decline.

Because of that oscillation, a single hormone panel usually cannot tell you where you are. STRAW+10 is explicit that menstrual criteria are the principal staging criteria and that FSH drawn at a random point is variable throughout the transition; it becomes informative mainly in the late transition, where STRAW+10 describes random FSH values above 25 IU/L as characteristic.

How STRAW+10 stages the transition using your cycle

STRAW+10 divides reproductive aging into stages anchored to the final menstrual period (FMP), designated stage 0. Everything before it is numbered negatively, everything after positively. The stages that matter for someone watching their periods change are −3a, −2, −1, and +1.

The practical value of the system is that it turns a vague question ('am I in perimenopause?') into an answerable one ('has my cycle length varied by 7 or more days between consecutive cycles, and has that recurred?'). Perimenopause, in STRAW+10 terms, spans the early menopausal transition through the 12 months following the final menstrual period.

Two timing facts are worth holding onto. STRAW+10 describes the late menopausal transition — the stage of 60-day-plus gaps — as lasting roughly 1 to 3 years, and it is the stage in which vasomotor symptoms are most likely to appear. Early postmenopause is described as lasting several years in total, with the first two stages (+1a and +1b) spanning about 2 years and +1c running roughly 3 to 6 years before hormone levels stabilize.

Symptom duration tracks these stages rather than the final period itself. The SWAN cohort, published in JAMA Internal Medicine in 2015, found that frequent hot flashes and night sweats persisted for a median of several years across the transition, and that women whose symptoms began before their cycles became irregular had the longest total course. This is why 'wait it out until your period stops' is poor advice for someone in the early transition.

Normal variability versus abnormal bleeding: where the line sits

The single most useful reframe is this: perimenopause explains changes in when you bleed. It does not, on its own, explain changes in how much you bleed, how long you bleed, or bleeding that happens outside a period. Timing chaos is the expected signature of ovarian aging. Volume and pattern problems have their own differential, and it is a differential that widens sharply in the 40s.

ACOG's patient guidance on heavy menstrual bleeding gives concrete thresholds rather than adjectives, which makes them usable at home: soaking through one or more pads or tampons every hour for several consecutive hours; needing to use double protection; needing to get up at night to change protection; bleeding lasting more than 7 days; passing blood clots the size of a quarter or larger; and bleeding heavy enough that it restricts daily activities. ACOG also lists symptoms of anemia — tiredness, fatigue, shortness of breath — as part of the picture.

ACOG's guidance on perimenopausal bleeding adds the pattern criteria: bleeding that occurs between periods, bleeding after sex, and cycles that become very short (arriving less than 21 days apart) all merit evaluation. Very short cycles are easy to dismiss as 'my periods are just closer together now,' but persistently bleeding every 2 to 3 weeks is a different phenomenon from cycle-to-cycle swings.

The practical rule that follows: track the outliers, not the average. A single 45-day cycle after a run of 27-day cycles is unremarkable. A single 12-day bleed, or one episode of hourly pad saturation, is worth a call even if every other cycle that year was ordinary.

Heavy bleeding and clots: why they happen and why they get missed

Heavy menstrual bleeding in the 40s usually has one of two engines behind it, and often both at once. The first is anovulation: without progesterone, the endometrium proliferates without the organized, synchronized shedding that a progesterone withdrawal bleed produces. What sheds instead is a thicker, structurally disorganized lining, and it sheds unpredictably. The second is a structural lesion — a fibroid, a polyp, or adenomyosis — that is either increasing the surface area of the endometrium or interfering with the uterus's ability to contract down on bleeding vessels.

Clots form when bleeding outpaces the fibrinolytic enzymes that normally keep menstrual blood liquid. Small clots on a heavy day are ordinary. ACOG uses the quarter-sized clot as its threshold precisely because it is a size anyone can judge without special equipment, and because clots that large signal a rate of blood loss that visual estimation consistently underestimates.

Iron depletion is the most common consequence and the most commonly missed one. Ferritin can fall well before hemoglobin does, and the resulting fatigue, exercise intolerance, hair shedding, and brain fog are readily attributed to perimenopause itself. If bleeding has been heavy for months, asking specifically for a ferritin level alongside a complete blood count is reasonable, because a normal hemoglobin does not rule out depleted stores.

Two situations deserve same-day attention rather than a routine appointment: bleeding heavy enough to soak through protection hourly for several consecutive hours, and heavy bleeding accompanied by dizziness on standing, a racing heart, or breathlessness. Those are volume-loss signals, not menstrual complaints.

Skipped periods, the 60-day marker, and the 12-month rule

A gap of 60 days or more without bleeding is not a failure of the system — it is a defined staging landmark. STRAW+10 uses it to mark entry into the late menopausal transition, the stage that typically runs 1 to 3 years and ends at the final menstrual period. Reaching it means the remaining time in the transition is more likely measured in years than in a decade.

Skipped cycles do not proceed in a straight line. It is entirely typical to miss two cycles, then have three regular ones, then miss four. Ovarian function in this stage is intermittent rather than exhausted, which has two implications: a returning period after a long gap is not abnormal, and ovulation — and therefore pregnancy — remains possible during and after those gaps.

Menopause itself is defined retrospectively. It is dated to the final menstrual period, and that period can only be identified after 12 consecutive months with no bleeding at all, as the Office on Women's Health and ACOG both describe. There is no blood test that can announce it prospectively, which is why clinicians are reluctant to declare menopause on the basis of an FSH result in a woman who is still cycling.

The 12-month clock resets with any bleeding. If you reach month 10 and bleed, the count restarts. But this is where a common and consequential error occurs: bleeding at month 13 is not a reset — it is postmenopausal bleeding, a different diagnostic category that ACOG says should always be evaluated.

Bleeding between periods and after sex

Intermenstrual bleeding — spotting or bleeding at a point in the cycle that is clearly not a period — is one of the patterns ACOG names as needing evaluation in perimenopause. It is not a normal feature of ovarian aging, even though it is extremely common in women who are also having irregular cycles.

The most frequent benign explanations are endometrial or cervical polyps, which bleed easily because they are vascular and mechanically exposed; a hormonal contraceptive or hormone therapy regimen that is producing breakthrough bleeding; and cervical or vaginal tissue that has become thin and fragile as estrogen falls. That last category — genitourinary syndrome of menopause — is described in the 2020 NAMS position statement and can cause light bleeding after intercourse purely from tissue friability.

Postcoital bleeding deserves separate mention because it points attention to the cervix specifically. Cervical polyps, cervicitis, and cervical dysplasia or cancer can all present this way. This is the scenario in which cervical cancer screening history genuinely matters: bleeding after sex in a woman who is overdue for screening, or who has a history of abnormal results, should prompt a speculum examination rather than a hormonal explanation.

The reason not to wait it out is that intermenstrual bleeding is also how endometrial hyperplasia and early endometrial cancer commonly present in perimenopausal women — before menopause, when the classic 'postmenopausal bleeding' warning does not yet apply. Perimenopause is precisely the window in which unopposed estrogen from anovulatory cycles has been acting on the endometrium for years.

Structural causes that become common in the 40s

Bleeding changes in this decade are frequently structural rather than purely hormonal, and the prevalence of every relevant structural cause rises with age up to menopause. Assuming a hormonal cause without examining the uterus is the single most common reason a treatable problem goes unaddressed for years.

Fibroids (leiomyomas) are benign smooth-muscle tumors of the uterus. Those that distort the uterine cavity — submucosal fibroids in particular — cause heavy and prolonged bleeding out of proportion to their size, while large fibroids elsewhere in the uterus more often cause pressure, urinary frequency, or abdominal distension. Fibroids typically shrink after menopause as estrogen falls, which is why the years just before menopause are often the worst.

Endometrial polyps are focal overgrowths of the lining. They classically produce intermenstrual spotting and light bleeding rather than heavy periods, and they are a common finding when perimenopausal bleeding is investigated. Most are benign, but they are removed both to stop the bleeding and to allow the tissue to be examined.

Adenomyosis is endometrial tissue growing within the muscular wall of the uterus. It tends to produce the combination of heavy bleeding plus genuinely painful, cramping periods and a uterus that feels diffusely enlarged and tender, and it is more common in women who have had children.

Endometrial hyperplasia is thickening of the lining, driven by prolonged estrogen exposure without progesterone. It is not itself cancer, but some forms — those with atypical cells — carry meaningful progression risk, which is why sampling the endometrium rather than simply treating the bleeding matters. Long stretches of anovulatory cycles, higher body weight (adipose tissue converts androgens to estrogen), and polycystic ovary syndrome all increase the exposure that drives it.

Non-uterine causes belong on the same list: thyroid dysfunction, undiagnosed inherited bleeding disorders such as von Willebrand disease (often present since the teenage years and finally noticed when bleeding worsens), and anticoagulant medications.

What evaluation actually involves

A first visit for perimenopausal bleeding is usually a history, an examination including a speculum exam of the cervix, blood tests, and imaging. The history is doing more work than it appears to — the sequence of when cycles changed, how many days you bleed, how often you saturate protection, whether bleeding occurs between periods, and what medications you take narrows the differential substantially before any test is ordered.

Typical laboratory work includes a complete blood count to detect anemia, a pregnancy test (which is not a formality — pregnancy remains possible until 12 months of amenorrhea), thyroid function, and, where the history suggests it, testing for a bleeding disorder. Ferritin is worth requesting explicitly if bleeding has been heavy over months.

Imaging is usually transvaginal ultrasound, which visualizes fibroids, measures the endometrium, and can suggest adenomyosis. Where a polyp or a submucosal fibroid is suspected but not clearly seen, saline infusion sonohysterography (fluid instilled into the cavity during ultrasound) or hysteroscopy gives a much better view of the cavity itself.

One point is frequently confused and worth stating plainly. ACOG's committee opinion on transvaginal ultrasonography describes an endometrial thickness of 4 mm or less as having a very high negative predictive value for endometrial cancer in women with postmenopausal bleeding, such that further evaluation is not required. That threshold is not validated for women who are still menstruating, because the endometrium normally varies in thickness across the cycle. If you are still having periods, a thin endometrium on ultrasound is not the reassurance it would be after menopause, and endometrial sampling may still be appropriate based on risk factors and bleeding pattern.

Endometrial biopsy is an office procedure in which a thin catheter samples the lining. It is generally recommended for perimenopausal women with abnormal bleeding, particularly with risk factors for hyperplasia — higher body weight, diabetes, polycystic ovary syndrome, long histories of anovulation, tamoxifen use, or a family history suggestive of Lynch syndrome.

Contraception when cycles are unpredictable

Fertility declines through the 40s but does not end at the first skipped period. Because ovulation in the late transition is intermittent rather than absent, a 60-day gap followed by an ovulatory cycle is a realistic scenario, and it is one in which someone who has stopped using contraception is unprotected. Pregnancy is possible until 12 consecutive months without bleeding have passed.

This is where a specific and consequential misunderstanding sits: menopausal hormone therapy is not contraception. The doses used for hot flashes and genitourinary symptoms, as described in the 2022 NAMS hormone therapy position statement, are not designed or approved to suppress ovulation. Someone using estrogen with progestogen for symptom relief while still having intermittent cycles needs a separate contraceptive method if pregnancy would be unwanted.

Choosing a method in perimenopause often means solving two problems at once, since several contraceptives also reduce bleeding. A levonorgestrel intrauterine system, for example, is contraception and one of the standard treatments for heavy menstrual bleeding, and it also provides the endometrial protection needed alongside systemic estrogen. Combined hormonal contraception can regulate erratic cycles and reduce flow, but its suitability depends on blood pressure, smoking status, migraine with aura, and clot risk — factors that more often become disqualifying in the 40s.

One practical consequence of hormonal methods: because they impose their own bleeding pattern, they mask the menstrual changes that STRAW+10 uses for staging. If you are on a method that suppresses or regularizes bleeding, you will not be able to identify your final menstrual period by observation, and the decision about when to stop contraception becomes a conversation with your clinician rather than something the calendar answers.

Tracking your cycle so it is actually useful at an appointment

Most perimenopausal appointments run aground on the same exchange: 'How heavy is it?' 'Heavy.' A few weeks of specific data changes the conversation and often changes the plan, because the clinical decisions turn on thresholds rather than impressions.

Record four things per cycle. First, the start date of every bleed, which lets anyone calculate cycle-to-cycle variation directly against the STRAW+10 7-day and 60-day criteria. Second, the number of days of bleeding, since more than 7 is a defined threshold. Third, saturation on your heaviest day — how many pads or tampons, how fully soaked, and whether you had to change hourly or overnight. Fourth, any bleeding that was not a period: date, amount, and whether it followed intercourse.

Add clots larger than a quarter as a yes/no note, and flag any day when bleeding stopped you doing something you would otherwise have done. That last item is not soft data; ACOG lists restriction of daily activities among the signs of heavy menstrual bleeding.

Bring the actual record, not a summary. Twelve dated entries let a clinician stage the transition, judge whether the bleeding meets evaluation criteria, and decide about imaging in a single visit rather than sending you away to track for three months first.

When irregular periods are not perimenopause

Age makes perimenopause the likeliest explanation for changing cycles in the 40s, but it does not make it the only one, and several alternatives are both treatable and easy to test for.

Thyroid disease produces the full range of menstrual disturbance — heavier, lighter, more frequent, absent — and its other symptoms (fatigue, temperature intolerance, weight change, mood change, hair thinning) overlap almost completely with perimenopause. A thyroid panel is standard in this workup for exactly that reason.

Pregnancy must be excluded before missed periods are attributed to ovarian aging, at any age, until 12 months of amenorrhea have passed.

Primary ovarian insufficiency is the diagnosis when ovaries stop working normally before age 40. As MedlinePlus describes, periods may become irregular or stop, and the condition is distinct from early menopause in that ovarian function can be intermittent. Someone under 40 with irregular or absent periods should be evaluated for POI rather than told she is 'starting perimenopause early,' because the diagnosis carries specific implications for bone health, cardiovascular health, and fertility counselling.

Medications and other conditions round out the list: anticoagulants, some antipsychotics and antidepressants that raise prolactin, high-dose corticosteroids, significant weight loss or gain, endurance training loads, and elevated prolactin from other causes can all disrupt cycles independently of ovarian aging.

Bleeding after menopause is a different category entirely

Once 12 consecutive months have passed without bleeding, the interpretive framework changes completely. Any bleeding after that point — a single spot on toilet paper, brown discharge, pink staining after sex — is postmenopausal bleeding, and ACOG's position is that it should always be evaluated. It is never dismissed as a late period, because by definition there are no more periods.

Most postmenopausal bleeding turns out to have a benign cause, most often atrophy of the endometrium or of the vaginal tissue, which the 2020 NAMS genitourinary syndrome of menopause statement describes as thinning and fragility of tissue after estrogen withdrawal. Polyps and hormone therapy regimens account for a further share.

The reason for the strict rule is the minority of cases. Postmenopausal bleeding is the most common presenting symptom of endometrial cancer, and endometrial cancer found early is highly treatable. The evaluation is designed around ruling it out first rather than last.

This is the setting in which the ACOG transvaginal ultrasound threshold applies: an endometrial thickness of 4 mm or less in a woman with postmenopausal bleeding has a very high negative predictive value for cancer, and ACOG states further evaluation is not required in that scenario. A thickness above 4 mm, or bleeding that recurs after an initially reassuring scan, calls for further assessment such as sonohysterography, hysteroscopy, or endometrial biopsy.

What can be done about the bleeding itself

Treatment follows the cause, which is why establishing the cause comes first. Where bleeding is driven by anovulation, the missing signal is progesterone, and the standard approaches restore it: a levonorgestrel intrauterine system, cyclic or continuous oral progestogen, or combined hormonal contraception in someone with no contraindication. These reduce flow and, when a period does arrive, make it more predictable.

Non-hormonal options address the bleeding mechanism rather than the hormonal driver. Antifibrinolytic medication taken during heavy days reduces measured blood loss, and non-steroidal anti-inflammatory drugs taken during the period reduce both flow and cramping. Both are taken only on bleeding days, which suits women who want intervention without ongoing hormonal treatment.

Where the cause is structural, treatment targets the structure. Polyps and cavity-distorting submucosal fibroids can be removed hysteroscopically, often resolving the bleeding outright. Larger fibroids have a range of options including uterine artery embolization and surgery. Endometrial ablation is an option for some women who have completed childbearing, though it is generally avoided where hyperplasia has not been excluded, since it destroys the tissue that would otherwise be sampled.

Iron replacement deserves explicit mention because it is often left out. If bleeding has been heavy for months, treating the bleeding without repleting iron leaves the fatigue in place for a long time afterward — stores take months to rebuild even once bleeding is controlled.

None of these decisions can be made from a web page. What a page can do is make sure you arrive at an appointment knowing that heavy bleeding in your 40s is a treatable problem with a specific differential, not an inevitable stage to be endured until periods stop on their own.

Questions to ask your clinician

Bring these to your appointment — they turn a vague visit into a decision.

• My cycles now vary by more than a week from one to the next — based on STRAW+10, which stage of the transition does that put me in?
• I've been bleeding for more than seven days and passing clots bigger than a quarter. Can we check a complete blood count and a ferritin level, and arrange a pelvic ultrasound?
• I'm having spotting between my periods. Can you examine my cervix and tell me whether I need a hysteroscopy or an endometrial biopsy rather than assuming it's hormonal?
• Given my age, weight, and how long my cycles have been irregular, am I at enough risk of endometrial hyperplasia to justify sampling the lining now?
• If my ultrasound shows a thin endometrium but I'm still having periods, does that actually rule anything out — or do we still need a biopsy?
• I'm still having occasional periods. What contraception do you recommend, and how will I know when it's safe to stop using it?
• If I start hormone therapy for hot flashes, will it change my bleeding pattern, and does it do anything for contraception?

Frequently asked questions

What is the first change in periods that signals perimenopause?

Usually a shortening of the cycle rather than irregularity. Cycles that ran 28 to 30 days may start arriving at 24 to 26 days as the follicular phase contracts. STRAW+10 places this in the late reproductive stage (−3a), described as subtle changes in flow or cycle length, before the true transition begins. The formal start of the early menopausal transition is a persistent difference of 7 days or more between consecutive cycle lengths.

How much cycle-length variation is normal in perimenopause?

Wide variation in timing is expected. STRAW+10 uses a persistent 7-day-or-greater difference between consecutive cycles to define the early menopausal transition, and gaps of 60 days or more to define the late transition — meaning swings of weeks are staging criteria, not warning signs. What is not expected is cycles arriving persistently closer than 21 days apart, which ACOG lists among the bleeding patterns that should be evaluated.

Are heavy periods normal in perimenopause?

Heavier flow than your previous baseline is common, because anovulatory cycles let the lining build without progesterone. But ACOG defines specific thresholds that warrant evaluation regardless of age: soaking a pad or tampon every hour for several consecutive hours, needing double protection, changing protection overnight, bleeding more than 7 days, or passing clots the size of a quarter or larger. Meeting any of those is a reason to be assessed, not to wait.

How long can you go without a period and still be in perimenopause?

Indefinitely, until 12 consecutive months have passed. A gap of 60 days or more marks entry into the late menopausal transition under STRAW+10, a stage that typically lasts 1 to 3 years, and periods can return after gaps of several months. Menopause is confirmed only retrospectively, after 12 full months with no bleeding at all.

Can I still get pregnant if my periods are irregular?

Yes. Ovulation in perimenopause is intermittent rather than absent, so a long gap can be followed by an ovulatory cycle. Pregnancy remains possible until 12 consecutive months without bleeding. Menopausal hormone therapy does not provide contraception — the doses used for hot flashes are not designed to suppress ovulation — so a separate method is needed if pregnancy would be unwanted.

Is spotting between periods normal in perimenopause?

No. ACOG lists bleeding between periods and bleeding after sex among the patterns that should be evaluated. Common causes include endometrial or cervical polyps, breakthrough bleeding on hormonal treatment, and fragile vaginal or cervical tissue from falling estrogen. It can also be how endometrial hyperplasia or early endometrial cancer presents before menopause, which is why it is investigated rather than watched.

Can a blood test tell me if I'm in perimenopause?

Not reliably while you are still cycling. STRAW+10 treats menstrual criteria as the principal staging criteria specifically because FSH is variable throughout the transition — a single draw can look premenopausal one month and menopausal the next. FSH becomes more informative in the late transition, where STRAW+10 describes random values above 25 IU/L as characteristic. Thyroid function and a pregnancy test are usually more useful early on.

Does an endometrial thickness of 4 mm mean I'm fine?

That threshold applies to postmenopausal bleeding, not to women who are still menstruating. ACOG's committee opinion describes a thickness of 4 mm or less in a woman with postmenopausal bleeding as having a very high negative predictive value for endometrial cancer, such that further evaluation is not required. Because the endometrium normally varies in thickness across a cycle, the same measurement does not carry that meaning in perimenopause, and biopsy may still be appropriate.

What if I bleed after going 12 months without a period?

That is postmenopausal bleeding and should always be evaluated, according to ACOG — including a single spot, brown discharge, or pink staining after sex. Most causes are benign, particularly atrophy of the endometrium or vaginal tissue, but postmenopausal bleeding is also the most common presenting symptom of endometrial cancer, which is highly treatable when found early.

Should I be tested for anemia if my periods are heavy?

It is reasonable to ask. ACOG lists tiredness, fatigue, and shortness of breath as symptoms accompanying heavy menstrual bleeding. A complete blood count detects anemia, but iron stores fall before hemoglobin does, so asking specifically about ferritin is worthwhile if bleeding has been heavy for months — a normal hemoglobin does not mean iron stores are intact.

Primary sources

1. Executive summary of the Stages of Reproductive Aging Workshop +10. J Clin Endocrinol Metab, 2012. PMID 22344196.
2. ACOG: Heavy Menstrual Bleeding (patient FAQ).
3. ACOG: Perimenopausal Bleeding and Bleeding After Menopause (patient FAQ).
4. ACOG Committee Opinion: Role of Transvaginal Ultrasonography in Evaluating the Endometrium With Postmenopausal Bleeding.
5. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022. PMID 35797481.
6. The 2020 genitourinary syndrome of menopause position statement of NAMS. Menopause, 2020. PMID 32852449.
7. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med, 2015. PMID 25686030.
8. MedlinePlus: Primary ovarian insufficiency.
9. Office on Women's Health: Menopause basics.